What are people asking about retatrutide?
What is retatrutide, and why are doctors testing it?
Doctors are testing the lab-made drug retatrutide for obesity and diabetes. This page gives short answers about what happened in studies and what remains unknown. The drug carries copied messages from three hormones made by your body.
In a 36-week Phase 2 study, a mid-sized test, people with type 2 diabetes received up to 12 mg. Their three-month blood sugar average fell −2.02%, and body weight fell −16.94% compared with placebo [2]. In a 48-week Phase 2 obesity study, 12 mg led to a −24.2% weight change [1]. Retatrutide has no health-agency approval, so it isn't a prescription medicine.
What does retatrutide do in your body?
Retatrutide copies three hormone messages linked with eating, sugar in the blood, and stored fuel. GLP-1 comes from the gut; it can ease hunger and help insulin as sugar climbs. Together, the messages may put more stored fuel to work, though a study can't say how you would feel.
In the Phase 2 obesity study, a mid-sized test, average weight changed −24.2% after 48 weeks. One review from 2025 called the change a large step beyond older drugs [6]. Retatrutide still hasn't been approved.
How does retatrutide work?
Retatrutide carries three copied hormone messages at once. GLP-1 comes from the gut; it can slow the stomach, ease hunger, and help insulin as blood sugar climbs. The second gut hormone helps with insulin too, while glucagon may put stored fuel to use.
In 2025, reviewers said glucagon may add a fuel-using effect that GLP-1 can't provide alone [9]. Close-up pictures showed retatrutide touching three cell proteins that normally receive those hormone messages [3]. That lab work explains the idea, but it can't predict your result.
How to reconstitute retatrutide: has any method been approved?
No approved method exists for mixing retatrutide powder into a shot. Retatrutide has no FDA label and has never been approved. Eli Lilly supplied ready-made shots in its studies, so the people taking part didn't mix anything.
Powder sold online may not match the drug used in those studies. No one has confirmed what is inside, how strong it is, or whether it carries germs. For that reason, this answer gives no mixing steps.
Is retatrutide FDA approved?
No. Retatrutide wasn't approved by the FDA or any similar agency in mid-2026. The maker had not finished its large Phase 3 studies.
Phase 3 is the late testing stage, when many more people are watched for benefit and harm. Good results would let the company request FDA approval. A prescription can't exist for you unless the FDA reviews that request and agrees.
When will retatrutide be available?
There is no firm date. The large Phase 3 studies must first show that the benefit is worth the harm. Eli Lilly would then need to request FDA approval, and the FDA could say yes or no.
In mid-2026, those Phase 3 studies were still running, and no request had been filed. Any date you see is a guess. Retatrutide might become a prescription drug, but approval isn't promised.
Where did doctors give the retatrutide shots?
Staff in every finished study gave retatrutide once a week as a shot into body fat [1][2][4]. They used an upper arm, a thigh, or the belly. They began with less drug, then made small increases to ease nausea and other gut trouble.
That only tells you what happened under close medical watch. It doesn't provide instructions for using the drug yourself. Retatrutide isn't approved, and no prescription product exists now.
How long does retatrutide take to work in studies?
In the 48-week Phase 2 obesity study, a mid-sized test, weight began changing during the first 8–12 weeks. Average loss was still growing when the study ended [1]. That group result can't show how fast you would respond.
In later talks, 31 of 36 people said their eating changed within 8 weeks [10]. A 2025 review also found that weight loss grew over time [6]. Larger studies may give a clearer answer.
Is retatrutide better than tirzepatide?
We don't know. No direct result was available by mid-2026, though a large Phase 3 comparison was running. A separate Phase 2 study tested tirzepatide, which copies GLP-1 plus another gut hormone, and found about 20% weight loss over 72 weeks.
The retatrutide Phase 2 study found about 24% over 48 weeks [1]. Different people took part, and the studies lasted different lengths of time. Separate results can't settle which medicine works better.
How much retatrutide did doctors test each week?
Phase 2, the mid-sized stage, tested weekly amounts from 1 mg through 12 mg [1]. People in the 12 mg group lost the most weight on average. They also had more side effects.
Study staff gave those amounts and checked each person's health. The numbers aren't directions for use outside a study. Retatrutide has no approved dose.
Can retatrutide be mixed with water treated against germs?
No mixing process for retatrutide has been approved. In studies, the maker supplied a ready-made shot. People didn't combine powder with bacteriostatic water, which is water treated to slow germ growth.
Untested research powder may contain the wrong thing or carry germs. A vial can look clean and still be unsafe. That is why this answer gives no mixing steps.
Can you switch from tirzepatide to retatrutide?
Published studies haven't given doctors a safe way to make that switch. Retatrutide isn't approved or sold by prescription, so a normal switch isn't possible now. No study has tested one.
If you take prescribed tirzepatide, speak with the doctor who knows your history and medicines. That doctor can weigh your sugar readings and the new problems a switch might bring. Online advice can't replace that personal talk.
Is retatrutide really a GLP-3 drug?
No. GLP-3 is a mistaken name, and the body has no GLP-3 hormone. Retatrutide copies two gut hormones, including GLP-1, plus glucagon [1][3].
Some online posts say GLP-3 because three hormone messages are involved. The shortcut is still wrong. In plain words, retatrutide copies three hormones; it doesn't act on anything by that name.
Can you get approved retatrutide now?
No approved retatrutide product is on the market. The known study drug is available only to people in an active trial. Material sold online for research isn't checked like prescription medicine.
During 2025, the FDA sent warning letters to more than 50 sellers of unapproved retatrutide. A vial's label can't prove its contents. This site doesn't name or support any seller of retatrutide.
What is retatrutide being studied for?
Doctors have studied retatrutide for obesity, type 2 diabetes, and fatty liver. No use had been approved anywhere in mid-2026. Your doctor still can't prescribe it.
A 2025 review brought together the early and mid-sized work, known as Phase 1/2 [6]. The review found that copying three hormones might help weight and blood sugar. That early hope isn't the same as approval.
Which three hormone messages does retatrutide copy?
Your body makes the three hormones that retatrutide copies. GLP-1 comes from the gut and helps with hunger and insulin. That GLP-1 message helps shape the drug, while glucagon may lift blood sugar and put stored fuel to use.
Close-up pictures showed retatrutide touching the proteins that normally receive all three messages [3]. The drug held to the GLP-1 protein differently than it held to the other two. The makers wanted some help from glucagon without raising blood sugar too much. One more GLP-1 lab test can explain the design, but it can't say what would happen to your weight or health.
What does the law say about selling or having retatrutide?
A controlled drug is one placed under special rules because it may be abused. Retatrutide isn't a controlled drug, but FDA law still treats it as an unapproved new drug. Selling it across the United States can break federal law, which is why the FDA warned sellers in 2025 and why you can't treat an online offer like a normal prescription.
Rules about having a study drug differ from place to place. This page can't give legal advice for your state or country. A local lawyer or public agency can answer that question.
How often did doctors give retatrutide in studies?
All published studies used a shot below the skin every week [1][2][4]. In the earliest small study, the blood amount dropped by half over a 6-day span [4]. That finding supported the weekly plan.
Weekly is the only timing tested in published work. It doesn't give you an approved schedule. Retatrutide still has no public dose or directions.
What does retatrutide's half-life mean in plain words?
That first human study put it at about 6 days [4]. Half-life tells you when the blood carries half the earlier amount. It doesn't tell you when every bit is gone.
The makers added a small fat-like tail to the drug. The tail holds to albumin, one of your blood's carrying proteins. That helps explain why the studies used weekly shots.
How was retatrutide stored during the studies?
Eli Lilly handled the study drug under strict drug-making rules. Staff kept it at set temperatures, away from light, and free of germs. They knew exactly which product they were giving.
Research powder sold online has no official storage rule. That material isn't a regulated medicine. A clean-looking vial can't offer that level of assurance.
Is retatrutide the same medicine as Ozempic?
No. Semaglutide, the drug in Ozempic, copies the gut hormone GLP-1. Retatrutide copies GLP-1, another gut hormone, and glucagon, so the two medicines aren't the same.
They also stand at different points in testing. The FDA has approved semaglutide for type 2 diabetes and weight care. Your doctor can't prescribe retatrutide because it remains a study drug.
Is retatrutide better than semaglutide?
No direct study has settled that question, so you can't call either drug better. A retatrutide Phase 2 study found about 24% weight loss over 48 weeks [1]. A separate semaglutide study, study 1 in that program, found about 15% over 68 weeks.
Different people took part, and the studies ran for different lengths of time. Retatrutide adds two hormone messages to GLP-1, which might bring a larger effect. Larger Phase 3 work must still show whether that possible edge holds.